Development of Protein Drugs of Alpha 5 Beta 1及Alpha v Beta 3 Integrin Antagonist for the Treatment of Angiogenesis-Related Diseases and Cancer Suppression

Project title

開發Alpha 5 Beta 1及Alpha v Beta 3 Integrin拮抗蛋白藥物在抑制血管新生相關疾病及治療腫瘤之應用

Internal ID

NSC98-2323-B002-007

Principal Investigator

Start Date

August 1, 2009

End Date

July 12, 2010

Partner Organizations

National Science and Technology Council